Angela Ostermann

Statistics

Publications

Citations

105

H-Index

Active since

2011

Affiliations

Boehringer Ingelheim (Germany)(Current)

Angela Ostermann is an author at Boehringer Ingelheim (Germany) specializing in medicine, src family activation, and tyrosine kinase inhibitor therapy.

Publications per year

2011–2017

Publications

Functional and Biochemical Rationales for the 24-Hour-Long Duration of Action of Olodaterol

Paola Casarosa, Ines Kollak, Tobias Kiechle et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 87 citations

Medicine, Pharmacology, Pharmacotherapy +17

Nintedanib inhibits pro-fibrotic mediators from T cells with relevance to connective tissue disease-associated interstitial lung disease

Lutz Wollin, Angela Ostermann, Cara Williams · 2017 · 18 citations

Medicine, Immunology, Pathobiology +16

1–2 of 2